Sequoia China co-leads $11m Series A in US medtech startup NuProbe

Medical equipment in an operating theatre

Early stage molecular diagnostics company NuProbe has announced the closing of a $11 million Series A round of funding led by Sequoia Capital China and Serica Partners to continue its development of ultra-sensitive, non-invasive blood test for the early detection of cancer and infectious diseases.

Other investors in the round, as per an official release, include WuXi AppTec Corporate Ventures, a fund specializing in growth capital for life sciences companies.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter